Clinical Trial

Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis

Name: Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis — clinical trial record (NCT07466511)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Researchers hypothesized that Bifidobacterium breve Supplement could reduce the progression rate of idiopathic scoliosis in children and potentially prevent the occurrence of new cases of scoliosis.

Trial Details

NCT Number	NCT07466511
Lead Sponsor	Second Affiliated Hospital of Wenzhou Medical University
Conditions	Idiopathic Scoliosis
Enrollment	100 participants
Start Date	2027-01-01
Primary Completion	2030-10-01 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-12